TITLE

Key Facts

PUB. DATE
November 2004
SOURCE
General Growth Properties, Inc. SWOT Analysis;November 2004, p4
SOURCE TYPE
SWOT Analysis
DOC. TYPE
Company Report
ABSTRACT
Presents key facts about General Growth Properties Inc., which is a real estate investment trust. Address and contact information; Revenues and financial year end data; Number of employees; SIC and NAICS codes; New York ticker.
ACCESSION #
16825596

 

Related Articles

  • SWOT Analysis.  // General Growth Properties, Inc. SWOT Analysis;November 2004, p5 

    Provides a business analysis of General Growth Properties Inc., which is a real estate investment trust, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths, including business position, nationwide presence, diversified tenant portfolio and...

  • General Growth Properties, Inc. SWOT Analysis.  // General Growth Properties, Inc. SWOT Analysis;November 2004, p1 

    Presents an overview of General Growth Properties Inc., which is a real estate investment trust. Company overview, including revenues generated in fiscal year 2003, services provided, and principal businesses; Key facts, including contact information; Analysis of the company, including...

  • Company Overview.  // General Growth Properties, Inc. SWOT Analysis;November 2004, p4 

    Presents an overview of General Growth Properties Inc., which is a real estate investment trust. Revenues generated in fiscal year 2003; Principal business offered, including shopping malls in the U.S.

  • SkyePharma SWOT Analysis.  // SkyePharma SWOT Analysis;November 2004, p1 

    Presents an overview of SkyePharma PLC, a company which specializes in the development of technologies for improving the way that drugs are given to patients, such as tablets that gradually release a dose into the body. Company overview, including revenues generated in fiscal year 2003, services...

  • Key Facts.  // SkyePharma SWOT Analysis;November 2004, p4 

    Presents key facts about SkyePharma PLC, a company which specializes in the development of technologies for improving the way that drugs are given to patients, such as tablets that gradually release a dose into the body. Address and contact information; Revenues and financial year end data;...

  • SWOT Analysis.  // SkyePharma SWOT Analysis;November 2004, p5 

    Provides a business analysis of SkyePharma PLC, a company which specializes in the development of technologies for improving the way that drugs are given to patients, such as tablets that gradually release a dose into the body, focusing on its strengths, weaknesses, opportunities for improvement...

  • GE Medical Systems SWOT Analysis.  // GE Medical Systems SWOT Analysis;May 2005, p1 

    Presents an overview of GE Healthcare, which is a provider of medical imaging, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceuticals services. Company overview, including revenues generated in fiscal year 2004, services provided, and principal...

  • Company Overview.  // GE Medical Systems SWOT Analysis;May 2005, p4 

    Presents an overview of GE Healthcare, which is a provider of medical imaging, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceuticals services. Revenues generated in fiscal year 2004; Principal business offered, including medical imaging and...

  • Key Facts.  // GE Medical Systems SWOT Analysis;May 2005, p4 

    Presents key facts about GE Healthcare, which is a provider of medical imaging, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceuticals services. Address and contact information; Revenues and financial year end data; Number of employees; SIC and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics